Mehravar Maryam, Shirazi Abolfazl, Mehrazar Mohammad Mehdi, Nazari Mahboobeh
Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Avicenna J Med Biotechnol. 2019 Jul-Sep;11(3):259-263.
The CRISPR/Cas9 genome editing system is a powerful and simple gene editing method. The format of the CRISPR components is one of the important factors in targeting efficiency. Compared to plasmid or mRNA (IVTs) format, using the CRISPR/Cas9 system as Cas9-crRNA-tracrRNA RNP format is more efficient and rapid, especially in minimizing some of the pitfalls of CRISPR-mediated gene editing. In addition to efficient applications of the CRISPR RNP format in a variety of cell types and organisms, another advantage of this approach is usability for applications in which the crRNAs in the tracrRNA-crRNA structure guides the Mg2+-dependent RNAdirected DNA endonuclease to introduce double-strand breaks at specific sites in DNA.
Here, Cas9-crRNA-tracrRNA RNP system was used to test the designed crRNAs for in vitro DNA cleavage by Cas9 protein in RAG1, RAG2 and IL2RG genes.
The results of cleavage reveal theCas9-crRNA-tracrRNA RNP system is a rapid and efficient way to pre-validate the efficiency of CRISPR cleavage with crRNAs designed for RAG1, RAG2 and IL2RG genes.
one step cleavage of DNA by CRISPR/Cas9 ribonucleoprotein complex can be used to pre-validate the functionality and relative efficiency of CRISPR system for targeting genes.
CRISPR/Cas9基因组编辑系统是一种强大且简单的基因编辑方法。CRISPR组件的形式是影响靶向效率的重要因素之一。与质粒或mRNA(体外转录物)形式相比,将CRISPR/Cas9系统用作Cas9 - crRNA - tracrRNA核糖核蛋白(RNP)形式更高效、快速,尤其在最小化CRISPR介导的基因编辑的一些缺陷方面。除了CRISPR RNP形式在多种细胞类型和生物体中的高效应用外,这种方法的另一个优势是可用于tracrRNA - crRNA结构中的crRNAs引导Mg2 +依赖的RNA定向DNA内切酶在DNA特定位点引入双链断裂的应用。
在此,使用Cas9 - crRNA - tracrRNA RNP系统来测试设计的crRNAs,以通过RAG1、RAG2和IL2RG基因中的Cas9蛋白进行体外DNA切割。
切割结果表明,Cas9 - crRNA - tracrRNA RNP系统是一种快速有效的方法,可预先验证为RAG1、RAG2和IL2RG基因设计的crRNAs的CRISPR切割效率。
CRISPR/Cas9核糖核蛋白复合物对DNA的一步切割可用于预先验证CRISPR系统靶向基因的功能和相对效率。